Drug Repositioning Service Global Market Report 2025

Description

Drug repositioning service involves the systematic identification of new therapeutic uses for existing drugs, enabling pharmaceutical companies to maximize the value of their current drug portfolios while reducing the risks associated with developing entirely new compounds. By leveraging existing clinical data and research, these services help streamline the drug development process, significantly decreasing the time and cost required to deliver effective treatments to patients.

The primary types of drug repositioning service are generic drugs and clinical trial failed drugs. Generic drugs are medications that contain the same active ingredients, strength, dosage form, and therapeutic effect as brand-name drugs but are generally offered at lower prices. The key therapeutic areas include oncology, neurology, infectious diseases, cardiovascular diseases, and other therapeutic areas. These services are utilized by various end users such as pharmaceutical companies, biotechnology firms, contract research organizations, academic research institutions, hospitals, and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The drug repositioning service market research report is one of a series of new reports from The Business Research Company that provides drug repositioning service market statistics, including drug repositioning service industry global market size, regional shares, competitors with a drug repositioning service market share, detailed drug repositioning service market segments, market trends and opportunities, and any further data you may need to thrive in the drug repositioning service industry. This drug repositioning service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug repositioning service market size has grown strongly in recent years. It will grow from $32.34 billion in 2024 to $34.2 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth during the historic period is driven by high attrition rates in traditional drug development, regulatory incentives such as orphan drug designation and fast-track approvals, advancements in computational biology and AI, rising healthcare costs, and availability of extensive clinical data from existing drugs.

The drug repositioning service market size is expected to see strong growth in the next few years. It will grow to $43.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be connected to increasing prevalence of chronic and complex diseases, continued advancements in AI and machine learning, growing focus on personalized medicine, expansion of global healthcare access, strengthening of intellectual property protections for repurposed drugs, collaborations between pharmaceutical companies and research institutions. Major trends in the forecast period include rising demand for cost-effective drug development, expansion of data-driven repurposing platforms, focus on rare and complex diseases, steady market growth across major regions, regulatory support for repositioning strategies, and increasing investment in predictive analytics and real-world data integration.

The rise in healthcare expenditures is expected to contribute to the growth of the drug repositioning service market going forward. Healthcare expenditures refer to the total funds allocated to health services, including prevention, treatment, rehabilitation, and administration. The increase in healthcare expenditures results from rising medical costs caused by technological advancements and the growing demand for healthcare services. Higher healthcare spending supports drug repositioning services by providing greater funding for clinical trials and research, which accelerates the discovery of new therapeutic uses for existing drugs. For instance, in March 2022, according to the 2021-2030 National Health Expenditure report published by the Centers for Medicare and Medicaid Services, a United States-based federal agency, national health spending is projected to increase by an average of 5.1 percent annually between 2021 and 2030, reaching nearly $6.8 trillion. Additionally, during the same period, Medicare spending is expected to rise at an annual rate of 7.2 percent, while Medicaid spending will grow at a rate of 5.6 percent. Therefore, the rise in healthcare expenditures is supporting the growth of the drug repositioning service market.

Leading players in the drug repositioning service market are emphasizing the use of artificial intelligence (AI) in drug repositioning, including computational drug repositioning systems that identify new therapeutic applications for existing drugs through AI-based analysis of scientific literature and biological data. A computational drug repositioning system is a technology-driven platform that applies artificial intelligence, machine learning, and data mining to systematically evaluate existing drugs, compounds, and biological datasets. For example, in November 2024, UBE and FRONTEO, two Japan-based companies, initiated a co-creation project that establishes a collaborative framework combining their expertise to strengthen drug repositioning initiatives. This project facilitates integration between dry research (data analysis) and wet research (biological testing), improving the process from hypothesis formulation to experimental verification. By utilizing FRONTEO's AI-driven Drug Discovery AI Factory and KIBIT technology, the initiative efficiently uncovers previously unreported links between diseases and molecular structures.

In January 2024, Cosmos Health Inc., a US-based healthcare group, acquired the Cloudscreen platform from Cloudpharm P.C. for an undisclosed amount. Through this acquisition, Cosmos Health Inc. aims to accelerate drug repurposing initiatives by utilizing Cloudscreen's AI platform to efficiently identify new therapeutic applications for existing drugs. Cloudpharm P.C. is a Greece-based company that provides drug repositioning services.

Major players operating in the drug repositioning service market are Recursion Pharmaceuticals Inc., Excelra, LifeArc, Cosmos Health Inc., Fios Genomics, Insilico Medicine Inc., Melior Discovery, Delta4, Acubiosys, VeriSIM Life, BioXcel Therapeutics Inc., Pharnext S.S., NuMedii, GVK Biosciences, Plex Research, Paradigm Biopharmaceuticals, BenevolentAI Limited

North America was the largest region in the drug repositioning service market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug repositioning service market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug repositioning service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug repositioning service market consists of revenues earned by entities by providing services such as target validation, pharmacovigilance support, formulation optimization, drug combination analysis, and post-marketing surveillance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Repositioning Service Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug repositioning service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug repositioning service ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug repositioning service market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Generic Drugs, Clinical Trial Failed Drugs
2) By Therapeutic Area: Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Other Therapeutic Area
3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations (CROs), Academic Research Institutions, Hospitals And Ambulatory Surgical Centers.
Subsegments:
1) By Generic Drugs: Small Molecule Drugs, Biologics, Biosimilars, Peptide-Based Drugs
2) By Clinical Trial Failed Drugs: Phase I Failed Drugs, Phase II Failed Drugs, Phase III Failed Drugs, Safety-Related Failed Drugs, Efficacy-Related Failed Drugs.
Companies Mentioned: Recursion Pharmaceuticals Inc., Excelra, LifeArc, Cosmos Health Inc., Fios Genomics, Insilico Medicine Inc., Melior Discovery, Delta4, Acubiosys, VeriSIM Life, BioXcel Therapeutics Inc., Pharnext S.S., NuMedii, GVK Biosciences, Plex Research, Paradigm Biopharmaceuticals, BenevolentAI Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r39211

1. Executive Summary

2. Drug Repositioning Service Market Characteristics

3. Drug Repositioning Service Market Trends And Strategies

4. Drug Repositioning Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drug Repositioning Service Growth Analysis And Strategic Analysis Framework

5.1. Global Drug Repositioning Service PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Drug Repositioning Service Market Growth Rate Analysis
5.4. Global Drug Repositioning Service Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Drug Repositioning Service Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Drug Repositioning Service Total Addressable Market (TAM)

6. Drug Repositioning Service Market Segmentation

6.1. Global Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Generic Drugs
Clinical Trial Failed Drugs
6.2. Global Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Neurology
Infectious Diseases
Cardiovascular Diseases
Other Therapeutic Areas
6.3. Global Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Companies
Biotechnology Firms
Contract Research Organizations (Cros)
Academic Research Institutions
Hospitals And Ambulatory Surgical Centers
6.4. Global Drug Repositioning Service Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Small Molecule Drugs
Biologics
Biosimilars
Peptide-Based Drugs
6.5. Global Drug Repositioning Service Market, Sub-Segmentation Of Clinical Trial Failed Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phase I Failed Drugs
Phase II Failed Drugs
Phase III Failed Drugs
Safety-Related Failed Drugs
Efficacy-Related Failed Drugs

7. Drug Repositioning Service Market Regional And Country Analysis

7.1. Global Drug Repositioning Service Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Drug Repositioning Service Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Repositioning Service Market

8.1. Asia-Pacific Drug Repositioning Service Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Repositioning Service Market

9.1. China Drug Repositioning Service Market Overview
9.2. China Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Repositioning Service Market

10.1. India Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Repositioning Service Market

11.1. Japan Drug Repositioning Service Market Overview
11.2. Japan Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Repositioning Service Market

12.1. Australia Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Repositioning Service Market

13.1. Indonesia Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Repositioning Service Market

14.1. South Korea Drug Repositioning Service Market Overview
14.2. South Korea Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Repositioning Service Market

15.1. Western Europe Drug Repositioning Service Market Overview
15.2. Western Europe Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Repositioning Service Market

16.1. UK Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Repositioning Service Market

17.1. Germany Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Repositioning Service Market

18.1. France Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Repositioning Service Market

19.1. Italy Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Repositioning Service Market

20.1. Spain Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Repositioning Service Market

21.1. Eastern Europe Drug Repositioning Service Market Overview
21.2. Eastern Europe Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Repositioning Service Market

22.1. Russia Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Repositioning Service Market

23.1. North America Drug Repositioning Service Market Overview
23.2. North America Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Repositioning Service Market

24.1. USA Drug Repositioning Service Market Overview
24.2. USA Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Repositioning Service Market

25.1. Canada Drug Repositioning Service Market Overview
25.2. Canada Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Repositioning Service Market

26.1. South America Drug Repositioning Service Market Overview
26.2. South America Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Repositioning Service Market

27.1. Brazil Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Repositioning Service Market

28.1. Middle East Drug Repositioning Service Market Overview
28.2. Middle East Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Repositioning Service Market

29.1. Africa Drug Repositioning Service Market Overview
29.2. Africa Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Repositioning Service Market Competitive Landscape And Company Profiles

30.1. Drug Repositioning Service Market Competitive Landscape
30.2. Drug Repositioning Service Market Company Profiles
- 30.2.1. Recursion Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Excelra Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. LifeArc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Cosmos Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Fios Genomics Overview, Products and Services, Strategy and Financial Analysis

31. Drug Repositioning Service Market Other Major And Innovative Companies

31.1. Insilico Medicine Inc.
31.2. Melior Discovery
31.3. Delta4
31.4. Acubiosys
31.5. VeriSIM Life
31.6. BioXcel Therapeutics Inc.
31.7. Pharnext S.S.
31.8. NuMedii
31.9. GVK Biosciences
31.10. Plex Research
31.11. Paradigm Biopharmaceuticals
31.12. BenevolentAI Limited
31.13. 0
31.14. 0
31.15. 0

32. Global Drug Repositioning Service Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Repositioning Service Market

34. Recent Developments In The Drug Repositioning Service Market

35. Drug Repositioning Service Market High Potential Countries, Segments and Strategies

35.1 Drug Repositioning Service Market In 2029 - Countries Offering Most New Opportunities
35.2 Drug Repositioning Service Market In 2029 - Segments Offering Most New Opportunities
35.3 Drug Repositioning Service Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer